CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
43 hedge funds and large institutions have $43.6M invested in Carisma Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.23% more ownership
Funds ownership: 1.21% → 1.43% (+0.23%)
10% less funds holding
Funds holding: 48 → 43 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Holders
43
Holding in Top 10
2
Calls
$2.48M
Puts
$155K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$1.96M | |
| 3 | +$1.88M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$1.39M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$300K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$258K | |
| 3 | -$151K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$129K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$68K |